Johnson & Johnson
Recent News About Johnson & Johnson View More
-
Philadelphia now the top-ranked 'Judicial Hellhole'; Massive verdicts, like $8B Risperdal case, cited
WASHINGTON – In an annual report of “Judicial Hellholes” released today by the American Tort Reform Association, Philadelphia has claimed the No. 1 ranking – in part due to a historic $8 billion punitive damages verdict rendered this year in litigation connected to Johnson & Johnson’s anti-psychotic drug Risperdal. -
Oklahoma judge feeds the 'monster' with $572M opioid ruling against Johnson & Johnson
Sixteen years ago in a case involving gunmaker Sturm, Ruger & Co., a New York appeals court refused to apply public nuisance law against the manufacturer of a legal product, saying that doing so would transform nuisance law “into a monster that would devour in one gulp the entire law of tort.” -
Private lawyers stand to make $90 million as judge hits Johnson & Johnson with $572M opioid ruling
NORMAN, Okla. (Legal Newsline) - A state judge in Oklahoma has blamed Johnson & Johnson for the state's opioid crisis and ordered it to pay $572 million in damages, extending public nuisance law beyond its traditional boundaries into what may become an all-purpose tool for government lawsuits against product manufacturers. -
Tensions run high in OK opioid trial Thursday; State focuses on risk data J&J relied on
NORMAN, Okla. (Legal Newsline) - Tensions ran high in court Thursday as the Oklahoma opioid trial continued, with defense attorney Larry Ottoway objecting throughout the day to opposing counsel's line of questioning directed at defense witness, business director for Janssen Pharmaceuticals Kimberly Deem-Eshleman. -
Father recounts loss of son in Oklahoma Johnson & Johnson opioid trial
NORMAN, Okla. (Legal Newsline) – Fighting back tears, a father who lost his son to an opioid overdose recounted the nightmare during testimony in a trial alleging that Johnson & Johnson flooded the state with addictive drugs for profit. -
Hunter: Case is about abating 'worst' man-made crisis; J&J: Case is about damages - not abatement
NORMAN, Okla. (Legal Newsline) - Admitting there is a high potential for abuse in opioid medications, Johnson & Johnson attorney Larry Ottaway said during opening arguments on Tuesday that physicians prescribing its medications Nucynta and Duragesic know this risk and have to know it to be licensed. -
Multidistrict litigation swamps courts as rules struggle to catch up; Is reform on the way?
Multidistrict litigation – sprawling cases sometimes involving thousands of plaintiffs from all over the country – now represents more than half of the civil caseload in federal courts, according to a new survey, yet defendants complain the rules governing them are largely judge-made and haphazardly enforced. -
Florida couple sues Ethicon, Johnson & Johnson alleging medical implant was defective
Medical companies seek to have the product liability case moved to U.S. DIstrict Court in Fort Lauderdale. -
Johnson & Johnson, Publix want talcum powder suit moved to U.S. District Court
FORT LAUDERDALE — Johnson & Johnson and Publix, defendants in a lawsuit alleging talcum powder products caused a woman's mesothelioma, have requested the case against them be moved from a state court to a U.S. District Court. -
Florida Justice Reform Institute calls on Johnson & Johnson to appeal $4.69 billion talc verdict
The Florida Justice Reform Institute says Johnson & Johnson should file an appeal after recently losing a $4.69 billion lawsuit in a St. Louis court over whether its talc powder products caused ovarian cancer.